These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30800111)

  • 1. Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine.
    Zhang F; Ma T; Cui P; Tamadon A; He S; Huo C; Yierfulati G; Xu X; Hu W; Li X; Shao LR; Guo H; Feng Y; Xu C
    Front Microbiol; 2019; 10():175. PubMed ID: 30800111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroacupuncture improves metabolic and ovarian function in a rat model of polycystic ovary syndrome by decreasing white adipose tissue, increasing brown adipose tissue, and modulating the gut microbiota.
    Zhang F; Ma T; Tong X; Liu Y; Cui P; Xu X; Shi J; Hu W; Lu W; Pei Z; Xu M; Li X; Xu C; Feng Y
    Acupunct Med; 2022 Aug; 40(4):347-359. PubMed ID: 34892981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization on gut microbiome of PCOS rats and its further design by shifts in high-fat diet and dihydrotestosterone induction in PCOS rats.
    Zheng Y; Yu J; Liang C; Li S; Wen X; Li Y
    Bioprocess Biosyst Eng; 2021 May; 44(5):953-964. PubMed ID: 32157446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex hormone related gut microbiota.
    He Y; Wang Q; Li X; Wang G; Zhao J; Zhang H; Chen W
    Food Funct; 2020 Jun; 11(6):5192-5204. PubMed ID: 32441726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the therapeutic potential of moxibustion on polycystic ovary syndrome: a rat model study on gut microbiota and metabolite interaction.
    Lin Y; Zeng H; Lin J; Peng Y; Que X; Wang L; Chen L; Bai N
    Front Cell Infect Microbiol; 2024; 14():1328741. PubMed ID: 38665877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
    Yurtdaş G; Akdevelioğlu Y
    J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice.
    Zhang H; Zheng L; Li C; Jing J; Li Z; Sun S; Xue T; Zhang K; Xue M; Cao C; Ouyang L; Qian Z; Xu R; He Z; Ma R; Chen L; Yao B
    J Ovarian Res; 2023 Jul; 16(1):138. PubMed ID: 37443082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interplay between PCOS pathology and diet on gut microbiota in a mouse model.
    Rodriguez Paris V; Wong XYD; Solon-Biet SM; Edwards MC; Aflatounian A; Gilchrist RB; Simpson SJ; Handelsman DJ; Kaakoush NO; Walters KA
    Gut Microbes; 2022; 14(1):2085961. PubMed ID: 35787106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diane-35 and metformin therapy in rats with endometrial lesions induced by dihydrotestosterone exposure.
    Liu Y; Xu R; Zhou Y; Wang Y; Zhang F; Tong X; Cui P; Ma T; Sun J; Feng Y; Li X
    Ann Transl Med; 2023 Mar; 11(6):247. PubMed ID: 37082665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of Gut Microbiota Alteration in the Patients and Animal Models with Polycystic Ovary Syndrome.
    Zhou J; Qiu X; Chen X; Ma S; Chen Z; Wang R; Tian Y; Jiang Y; Fan L; Wang J
    J Microbiol; 2023 Sep; 61(9):821-836. PubMed ID: 37824034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway.
    Zhang S; Tu H; Yao J; Le J; Jiang Z; Tang Q; Zhang R; Huo P; Lei X
    Reprod Biol Endocrinol; 2020 Jun; 18(1):58. PubMed ID: 32493421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Polycystic Ovary Syndrome and Gut Microbiota.
    Guo Y; Qi Y; Yang X; Zhao L; Wen S; Liu Y; Tang L
    PLoS One; 2016; 11(4):e0153196. PubMed ID: 27093642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive and Behavior Dysfunction Induced by Maternal Androgen Exposure and Obesity Is Likely Not Gut Microbiome-Mediated.
    Lindheim L; Manti M; Fornes R; Bashir M; Czarnewski P; Diaz OE; Seifert M; Engstrand L; Villablanca EJ; Obermayer-Pietsch B; Stener-Victorin E
    J Endocr Soc; 2018 Dec; 2(12):1363-1380. PubMed ID: 30534630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balancing Act: Exploring the Gut Microbiota-Brown Adipose Tissue Axis in PCOS Pathogenesis and Therapeutic Frontiers.
    Li Y; Fang Y; Wang H; Zhang H
    Front Biosci (Landmark Ed); 2024 May; 29(6):208. PubMed ID: 38940030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet.
    Yang J; Wang E; Jiang M; Tan Y; Yao F; Sun C; Pan L; Gao L; Yao J
    J Ovarian Res; 2023 Jun; 16(1):109. PubMed ID: 37277785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine Improves the Symptoms of DHEA-Induced PCOS Rats by Regulating Gut Microbiotas and Metabolites.
    Shen HR; Xu X; Ye D; Li XL
    Gynecol Obstet Invest; 2021; 86(4):388-397. PubMed ID: 34515131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine interacts with gut microbiota and its potential therapy for polycystic ovary syndrome.
    Zhu TW; Li XL
    Clin Exp Pharmacol Physiol; 2023 Nov; 50(11):835-843. PubMed ID: 37604463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome.
    Zhang Y; Zhao W; Xu H; Hu M; Guo X; Jia W; Liu G; Li J; Cui P; Lager S; Sferruzzi-Perri AN; Li W; Wu XK; Han Y; Brännström M; Shao LR; Billig H
    J Physiol; 2019 Aug; 597(15):3927-3950. PubMed ID: 31206177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics.
    Singh S; Pal N; Shubham S; Sarma DK; Verma V; Marotta F; Kumar M
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.